Management of stage III non-small cell lung cancer

被引：42

作者：

Tabchi, Samer ^{[1
]}

Kassouf, Elie ^{[1
]}

El Rassy, Elie ^{[2
]}

Kourie, Hampig Raphael ^{[3
]}

Martin, Jocelyne ^{[4
]}

Campeau, Marie-Pierre ^{[5
]}

Tehfe, Mustapha ^{[1
]}

Blais, Normand ^{[1
]}

机构：

[1] Ctr Hosp Univ Montreal, Med Oncol Dept, Montreal, PQ, Canada

[2] St Joseph Univ, Fac Med, Hotel Dieu France, Univ Hosp, Beirut, Lebanon

[3] Univ Libre Bruxelles, Jules Bordet Inst, Oncol Dept, Brussels, Belgium

[4] Ctr Hosp Univ Montreal, Dept Thorac Surg, Montreal, PQ, Canada

[5] Ctr Hosp Univ Montreal, Radiat Oncol Dept, Montreal, PQ, Canada

来源：

SEMINARS IN ONCOLOGY | 2017年 / 44卷 / 03期

关键词：

Non-small cell lung cancer; stage III; chemotherapy; radiotherapy; surgery; combined modality; RANDOMIZED PHASE-III; INDIVIDUAL PATIENT DATA; TRANSBRONCHIAL NEEDLE ASPIRATION; POSTOPERATIVE RADIATION-THERAPY; TRIALIST ASSOCIATION ANITA; INDUCTION CHEMOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; CONSOLIDATION CHEMOTHERAPY; THORACIC RADIOTHERAPY; SEQUENTIAL CHEMORADIOTHERAPY;

D O I：

10.1053/j.seminoncol.2017.10.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Optimal management of patients with locally advanced non-small cell lung cancer remains challenging in the context of this heterogeneous disease. Despite aggressive therapeutic approaches, survival benefits are still unsatisfactory for what might be viewed as a localized malignancy. A combined modality approach offers patients superior outcomes, especially because technological advances and refined surgical procedures now provide better results with fewer complications. Nevertheless, several features of therapy remain controversial and lack formal prospective data. Traditional cytotoxic chemoradiation therapy may have reached a plateau and future perspectives opting to integrate molecularly targeted agents and immunotherapy might be the way to improve outcomes in this disease subset. (C) 2017 Elsevier Inc. All rights reserved.

引用

页码：163 / 177

页数：15

共 80 条

[21] Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma [J].

Das, Amit K. ;

Chen, Benjamin P. ;

Story, Nhchael D. ;

Sato, Mitsuo ;

Minna, John D. ;

Chen, David J. ;

Nirodi, Chaitanya S. .

CANCER RESEARCH, 2007, 67 (11) :5267-5274

[22] Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival [J].

Decaluwe, Herbert ;

De Leyn, Paul ;

Vansteenkiste, Johan ;

Dooms, Christophe ;

Van Raemdonck, Dirk ;

Nafteux, Philippe ;

Coosemans, Willy ;

Lerut, Toni .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (03) :433-439

[23] Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial [J].

Dillman, RO ;

Herndon, J ;

Seagren, SL ;

Eaton, WL ;

Green, MR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1210-1215

[24] A RANDOMIZED TRIAL OF INDUCTION CHEMOTHERAPY PLUS HIGH-DOSE RADIATION VERSUS RADIATION ALONE IN STAGE-III NON-SMALL-CELL LUNG-CANCER [J].

DILLMAN, RO ;

SEAGREN, SL ;

PROPERT, KJ ;

GUERRA, J ;

EATON, WL ;

PERRY, MC ;

CAREY, RW ;

FREI, EF ;

GREEN, MR .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :940-945

[25] Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Mediastinal Staging of Non-Small Cell Lung Cancer: A Meta-Analysis [J].

Dong, Xifeng ;

Qiu, Xiaochun ;

Liu, Qian ;

Jia, Jack .

ANNALS OF THORACIC SURGERY, 2013, 96 (04) :1502-1507

[26] Impact of postoperative radiation therapy on survival in patients with complete resection and Stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) randomized trial [J].

Douillard, Jean-Yves ;

Rosell, Rafael ;

De Lena, Mario ;

Riggi, Marcello ;

Hurteloup, Patrick ;

Mahe, Marc-Andre .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03) :695-701

[27] Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial [J].

Douillard, Jean-Yves ;

Rosell, Rafael ;

De Lena, Mario ;

Carpagnano, Francesco ;

Ramlau, Rodryg ;

Gonzales-Larriba, Jose Luis ;

Grodzki, Tornasz ;

Pereira, Jose Rodrigues ;

Le Groumellec, Alain ;

Lorusso, Vito ;

Clary, Claude ;

Torres, Antonio J. ;

Dahabreh, Jabrail ;

Souquet, Pierre-Jean ;

Astudillo, Julio ;

Fournel, Pierre ;

Artal-Cortes, Angel ;

Jassem, Jacek ;

Koubkova, Leona ;

His, Patricia ;

Riggi, Marcella ;

Hurteloup, Patrick .

LANCET ONCOLOGY, 2006, 7 (09) :719-727

[28] Safety and feasibility of consolidation pembrolizumab following concurrent chemoradiation for unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN14-179. [J].

Durm, Greg Andrew ;

Johnson, Cynthia ;

Jalal, Shadia Ibrahim ;

Sadiq, Ahad Ali ;

Jabbour, Salma ;

Zon, Robin ;

Kloecker, Goetz H. ;

Reckamp, Karen L. ;

Fisher, William B. ;

Hanna, Nasser H. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[29] 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer [J].

Eberhardt, W. E. E. ;

De Ruysscher, D. ;

Weder, W. ;

Le Pechoux, C. ;

De Leyn, P. ;

Hoffmann, H. ;

Westeel, V. ;

Stahel, R. ;

Felip, E. ;

Peters, S. .

ANNALS OF ONCOLOGY, 2015, 26 (08) :1573-1588

[30] Preoperative Staging of Lung Cancer with Combined PET-CT. [J].

Fischer, Barbara ;

Lassen, Ulrik ;

Mortensen, Jann ;

Larsen, Soren ;

Loft, Annika ;

Bertelsen, Anne ;

Ravn, Jesper ;

Clementsen, Paul ;

Hogholm, Asbjorn ;

Larsen, Klaus ;

Rasmussen, Torben ;

Keiding, Susanne ;

Dirksen, Asger ;

Gerke, Oke ;

Skov, Birgit ;

Steffensen, Ida ;

Hansen, Hanne ;

Vilmann, Peter ;

Jacobsen, Grete ;

Backer, Vibeke ;

Maltbaek, Niels ;

Pedersen, Jesper ;

Madsen, Henrik ;

Nielsen, Henrik ;

Hojgaard, Liselotte .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) :32-39

← 1 2 3 4 5 6 7 8 →